Categories
Brands
Active Ingredient
Warehouses
Tirzepatide
Tirzepatide is a novel investigational medicine developed by Eli Lilly and Company for the treatment of type 2 diabetes. It belongs to a class of drugs called GLP-1 receptor agonists (glucagon-like peptide-1).
By stimulating both GLP-1 and GIP receptors, tirzepatide helps to lower blood sugar levels in people with type 2 diabetes by increasing insulin secretion and reducing glucagon secretion in a glucose-dependent manner. Additionally, GLP-1 receptor agonists like tirzepatide have been shown to promote weight loss and may have beneficial effects on cardiovascular health.
Read More DetailsThe information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.